2 years ago
RXDX
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 6%
#293 out of 4937 analysts
Average Return
+11.51%
Win Rate
42%96 out of 229
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Adc Therapeutics SaADCT | +388.33% | $0.60 | $2.93 | 2023-11-08 - 2024-11-07 | Buy |
Nurix Therapeutics IncNRIX | +340.50% | $5.56 | $24.47 | 2023-11-02 - 2024-11-01 | Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-03 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | 3 | Buy | $35.00 | -30.74% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 14 | Buy | $26.00 | +23.93% | Reiterates | 2 months ago |
Adc Therapeutics SaADCT | 12 | Buy | $8.00 | +153.97% | Reiterates | 2 months ago |
Inovio Pharmaceuticals IncINO | 11 | Hold | $5.00 | +267.65% | Reiterates | 2 months ago |
Exelixis IncEXEL | 10 | Buy | $40.00 | -10.83% | Reiterates | 2 months ago |
Beone Medicines LtdONC | 2 | Buy | $311.00 | +24.25% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 14 | Buy | $172.00 | +55.98% | Maintains | 2 months ago |
Bicycle Therapeutics PLCBCYC | 3 | Buy | $32.00 | +300.00% | Maintains | 2 months ago |
Amgen IncAMGN | 17 | Buy | $320.00 | +8.38% | Maintains | 2 months ago |
Cg Oncology IncCGON | 3 | Buy | $68.00 | +154.49% | Maintains | 3 months ago |
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | +502.41% | Maintains | 3 months ago |
Perspective Therapeutics IncCATX | 6 | Buy | $15.00 | +276.88% | Maintains | 4 months ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | +6.95% | Reiterates | 4 months ago |
Verastem IncVSTM | 10 | Buy | $14.00 | +199.15% | Maintains | 4 months ago |
Nurix Therapeutics IncNRIX | 11 | Buy | $27.00 | +117.04% | Maintains | 6 months ago |
Ideaya Biosciences IncIDYA | 12 | Buy | $61.00 | +171.35% | Reiterates | 6 months ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | -21.40% | Reiterates | 6 months ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | +1,267.52% | Maintains | 6 months ago |
Nuvation Bio IncNUVB | 6 | Buy | $10.00 | +354.55% | Reiterates | 6 months ago |
Mannkind CorpMNKD | 1 | Buy | $10.00 | +165.25% | Upgrades | 7 months ago |
Viridian Therapeutics IncVRDN | 11 | Buy | $47.00 | +175.82% | Maintains | 7 months ago |
Agios Pharmaceuticals IncAGIO | 6 | Buy | $57.00 | +45.97% | Maintains | 7 months ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | +2,464.10% | Maintains | 8 months ago |
Fulcrum Therapeutics IncFULC | 3 | Hold | $4.00 | -48.91% | Reiterates | 8 months ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $2.00 | +147.83% | Downgrades | 8 months ago |
Xencor IncXNCR | 8 | Buy | $34.00 | +285.05% | Maintains | 10 months ago |
Atyr Pharma IncATYR | 6 | Buy | $16.00 | +201.89% | Reiterates | a year ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | +0.02% | Reiterates | a year ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | a year ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | a year ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | 2 years ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 2 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 2 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 2 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 3 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 3 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 4 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 6 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.